178 related articles for article (PubMed ID: 34100186)
1. Thyroid nodules with indeterminate cytology: association between nodule size, histopathological characteristics and clinical outcome in differentiated thyroid carcinomas - a multicenter retrospective cohort study on 761 patients.
Cozzani F; Bettini D; Rossini M; Bonati E; Nuzzo S; Loderer T; Pedrazzi G; Zaccaroni A; Del Rio P
Updates Surg; 2021 Oct; 73(5):1923-1930. PubMed ID: 34100186
[TBL] [Abstract][Full Text] [Related]
2. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
4. Incidence and malignancy rates of indeterminate pediatric thyroid nodules.
Wang H; Mehrad M; Ely KA; Liang J; Solórzano CC; Neblett WW; Coogan AC; Weiss VL
Cancer Cytopathol; 2019 Apr; 127(4):231-239. PubMed ID: 30768868
[TBL] [Abstract][Full Text] [Related]
5. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
7. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic lobectomy is not routinely required to exclude malignancy in thyroid nodules greater than four centimetres.
Raj MD; Grodski S; Woodruff S; Yeung M; Paul E; Serpell JW
ANZ J Surg; 2012; 82(1-2):73-7. PubMed ID: 22507501
[TBL] [Abstract][Full Text] [Related]
9. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
11. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
12. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
Seagrove-Guffey MA; Hatic H; Peng H; Bates KC; Odugbesan AO
Cancer Cytopathol; 2018 Oct; 126(10):881-888. PubMed ID: 30335212
[TBL] [Abstract][Full Text] [Related]
13. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
[TBL] [Abstract][Full Text] [Related]
15. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
16. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Kim M; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Feb; 29(2):216-221. PubMed ID: 30421654
[TBL] [Abstract][Full Text] [Related]
17. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
18. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
Sahin M; Gursoy A; Tutuncu NB; Guvener DN
Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
[TBL] [Abstract][Full Text] [Related]
20. False negative cytology in large thyroid nodules.
Giles WH; Maclellan RA; Gawande AA; Ruan DT; Alexander EK; Moore FD; Cho NL
Ann Surg Oncol; 2015 Jan; 22(1):152-7. PubMed ID: 25074665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
